You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 康寧傑瑞(9966.HK)漲超5% 將發佈KN046及KN026的研究進展
格隆匯 05-10 09:51
格隆匯5月10日丨康寧傑瑞(9966.HK)高開高走,現漲5.57%報14.4港元,暫成交1484萬港元,最新總市值134億港元。康寧傑瑞上週五(7日)晚間發公吿稱,將於2021年美國臨牀腫瘤學會年會以摘要及海報呈列發佈KN046(一種重組人源化PD-L1/CTLA-4雙特異性抗體)及KN026(一種基於Fc的抗HER2雙特異性抗體)的研究進展,美國臨牀腫瘤學會為醫生及腫瘤學專業人士關愛癌症患者的世界領先專業機構。據悉,KN046的臨牀前及臨牀試驗結果展現出良好的療效,並表明可顯著減少對人體外周系統可能產生的毒副作用。公司認為,KN046有望成為突破性腫瘤免疫特效藥。此外,KN026正在中國進行數項I/II期臨牀試驗,並在美國進行一項I期臨牀試驗。KN026已在晚期乳腺癌患者中表現出良好的初步療效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account